Skip to main content
Menu
US

IVISbrite HT-29 Red F-luc Bioluminescent Tumor Cell line (Bioware Brite)

The IVISbrite™ HT29 Red F-luc tumor cell line (Bioware® Brite HT-29-Red-FLuc) is a light-producing cell line derived from HT29-human colorectal adenocarcinoma. The cells have been stably transduced with the red-shifted firefly luciferase gene from Luciola Italica (Red F-luc), for a brighter, red-shifted signal.

For research use only. Not for use in diagnostic procedures.

The IVISbrite™ HT29 Red F-luc tumor cell line (Bioware® Brite HT-29-Red-FLuc) is a light-producing cell line derived from HT29-human colorectal adenocarcinoma. The cells have been stably transduced with the red-shifted firefly luciferase gene from Luciola Italica (Red F-luc), for a brighter, red-shifted signal.

For research use only. Not for use in diagnostic procedures.

Overview

IVISbrite HT-29 Red F-luc Bioluminescent Tumor Cell line

  • Organism: Human
  • Tissue: Colon
  • Disease: Colorectal Adenocarcinoma
  • Optical Reporter: Red F-Luc

This cell line has very bright bioluminescence, emitting at least 30,000 photons/cell/sec in vitro. The exact number will vary depending on imaging and culturing conditions.

By emitting intensified, longer wavelength light that is significantly brighter than other firefly luciferases, our bioluminescent oncology cell lines allow you to visualize and monitor the growth of deep tissue tumors in vivo.

After the cells are injected into an appropriate mouse model, the optimized Red F-luc luciferase enables more sensitive in vivo optical detection with less tissue attenuation so you can detect tumor development earlier.

Specifications

Brand
IVISbrite
Cancer Model
Colorectal
Imaging Modality
Bioluminenscence
Luciferase Classification
Firefly
Shipping Conditions
Shipped in Dry Ice
Unit Size
2 vials each containing 1 million cells

Resources

Are you looking for resources, click on the resource type to explore further.

1-1 of 1 Resources
faq icon
FAQ
IVISbrite Tumor cell lines and substrates
Scroll Icon